Brittney S. Harrington

Also affiliated with National Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells”.

Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells

Frontiers in Oncology(2022)10.3389/fonc.2022.762820

N/A

0.500DataRank · unranked

27 citations

Brittney S. Harrington, Rahul Kamdar, Michael J. Kruhlak, Christina M. Annunziata, Michael W. Caminear

NF-κB Signaling Modulates miR-452-5p and miR-335-5p Expression to Functionally Decrease Epithelial Ovarian Cancer Progression in Tumor-Initiating Cells

International Journal of Molecular Sciences(2023)10.3390/ijms24097826

N/A

0.330DataRank · unranked

8 citations

Brittney S. Harrington, Emma Attar, Soumya Korrapati, Jyoti Shetty, Yongmei Zhao +5 more

UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer

Journal of Experimental & Clinical Cancer Research(2023)10.1186/s13046-023-02820-z

N/A

0DataRank · unranked

15 citations

Rahul Kamdar, Franklin Ning, Soumya Korrapati, Michael W. Caminear, Lídia Hernandez +18 more

Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer

Research Square(2023)10.21203/rs.3.rs-3399502/v1

N/A

0DataRank · unranked

1 citations

Kei Kudo, Yoshimi Endo Greer, Teruhiko Yoshida, Brittney S. Harrington, Soumya Korrapati +6 more

Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer

Cancer Gene Therapy(2024)10.1038/s41417-024-00748-w

N/A

0DataRank · unranked

11 citations

Yoshimi Endo Greer, Teruhiko Yoshida, Brittney S. Harrington, Soumya Korrapati, Yusuke Shibuya +6 more

Targeting Metabolic Vulnerability by Combining NAMPT Inhibitors and Disulfiram for Treatment of Recurrent Ovarian Cancer

Research Square(2024)10.21203/rs.3.rs-4150814/v1

N/A

0DataRank · unranked

0 citations

Kei Kudo, Daniel R. Crooks, Yoshimi Endo Greer, Ye Yang, Jeffrey Brender +10 more

Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model

Cancers(2020)10.3390/cancers12061645

N/A

0DataRank · unranked

41 citations

Michelle Ozaki, Michael W. Caminear, Lídia Hernandez, Elizabeth Jordan, Nicholas J. Kalinowski +10 more

Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancer

Cell Death and Disease(2025)10.1038/s41419-025-07672-3

N/A

0DataRank · unranked

4 citations

Yoshimi Endo Greer, Daniel R. Crooks, Ye Yang, Jeffrey Brender, Teruhiko Yoshida +10 more

UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.07.509566

N/A

0DataRank · unranked

2 citations

Rahul Kamdar, Franklin Ning, Soumya Korrapati, Michael W. Caminear, Lídia Hernandez +18 more